ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1454

$1.38M Total Retail Price of All Prescriptions

Rank: 30 out of 1454

800 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 800 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 800 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 23,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
WARFARIN SODIUM 1,125 1,021 1 17
OMEPRAZOLE 985 891 2 3
HYDROCODONE-ACETAMINOPHEN 953 750 S3 3 7
LEVOTHYROXINE SODIUM 899 820 4 5
SIMVASTATIN 828 708 5 1
LISINOPRIL 752 686 6 4
AMLODIPINE BESYLATE 619 573 7 2
BUMETANIDE 547 524 8 149
CARVEDILOL 490 434 9 24
ATORVASTATIN CALCIUM 478 407 10 11
METOPROLOL TARTRATE 475 408 11 10
ATENOLOL 474 437 12 18
SERTRALINE HCL 442 369 13 26
PRAVASTATIN SODIUM 439 363 14 12
METFORMIN HCL 412 328 15 8
CITALOPRAM HBR 340 268 16 21
GABAPENTIN 338 275 17 16
POTASSIUM CHLORIDE 297 279 18 15
DONEPEZIL HCL 294 294 19 29
MIRTAZAPINE 279 241 20 53
CRESTOR 273 236 21 22
ZOLPIDEM TARTRATE 263 202 22 19
DIOVAN 255 239 23 40
HYDROCHLOROTHIAZIDE 233 201 24 9
TRAMADOL HCL 226 193 25 20
ISOSORBIDE MONONITRATE ER 223 209 26 46
LABETALOL HCL 220 218 27 147
RANITIDINE HCL 219 199 28 43
METOPROLOL SUCCINATE 215 182 29 13
JANUVIA 214 166 30 77
ALBUTEROL SULFATE 213 197 31 178
NAMENDA 209 199 32 48
FUROSEMIDE 203 156 33 6
NEXIUM 203 108 33 23
ALLOPURINOL 188 166 35 28
DIGOXIN 188 176 35 70
TAMSULOSIN HCL 184 160 37 34
TRAZODONE HCL 182 123 38 50
FENTANYL 174 147 S2 39 104
LOSARTAN POTASSIUM 170 124 40 14
CLOPIDOGREL 168 142 41 32
CYMBALTA 161 90 42 55
TORSEMIDE 158 154 43 125
ENALAPRIL MALEATE 156 136 44 58
ALENDRONATE SODIUM 152 150 45 35
LIPITOR 152 128 45 74
NOVOLOG 144 132 47 99
PREDNISONE 141 125 48 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 140 106 49 108
ADVAIR DISKUS 138 107 50 47
AZITHROMYCIN 134 107 51 42
CEPHALEXIN 132 128 52 127
KLOR-CON M20 127 115 53 54
PROMETHAZINE HCL 127 107 R 53 82
CEFUROXIME 121 114 55 150
DILTIAZEM 24HR CD 118 118 56 76
CLOTRIMAZOLE-BETAMETHASONE 118 69 56 166
CLONIDINE HCL 118 90 56 49
PLAVIX 116 100 59 45
OXYCODONE HCL 115 81 S2 60 80
LANTUS 113 84 61 51
PAROXETINE HCL 110 93 62 73
PROAIR HFA 110 61 62 56
PANTOPRAZOLE SODIUM 110 100 62 31
LEVETIRACETAM 107 52 65 114
FAMOTIDINE 107 95 65 88
FLUTICASONE PROPIONATE 107 65 65 30
BISOPROLOL-HYDROCHLOROTHIAZIDE 105 99 68 124
GLYBURIDE MICRONIZED 101 90 R 69 316
GLIPIZIDE 96 96 70 62
TAMIFLU 95 87 71 248
ACTOS 94 72 72 90
SPIRONOLACTONE 93 62 73 63
SINGULAIR 92 63 74 83
DILTIAZEM 24HR ER 85 73 75 120
DIVALPROEX SODIUM 85 68 75 106
METFORMIN HCL ER 84 73 77 41
RESTASIS 84 66 77 267
SYNTHROID 82 69 79 25
CIPROFLOXACIN HCL 82 75 79 64
CYCLOBENZAPRINE HCL 80 50 R 81 59
MELOXICAM 80 58 81 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 77 83 27
CARBIDOPA-LEVODOPA 76 76 84 130
VENLAFAXINE HCL ER 74 52 85 105
DIOVAN HCT 73 59 86 75
LOVASTATIN 70 58 87 39
DILTIAZEM HCL 70 68 87 255
IPRATROPIUM BROMIDE 70 55 87 221
FINASTERIDE 69 69 90 94
MONTELUKAST SODIUM 69 51 90 144
DEXAMETHASONE SODIUM PHOSPHATE 69 69 90 431
RAMIPRIL 69 69 90 66
PHENYTOIN SODIUM EXTENDED 68 26 94 138
FENOFIBRATE 67 56 95 68
SPIRIVA 64 64 96 52
AMOXICILLIN 64 59 96 133
DOXYCYCLINE HYCLATE 63 51 98 110
KLOR-CON 10 63 63 98 141
BACLOFEN 63 27 98 146
AMIODARONE HCL 62 62 101 223
KLOR-CON M10 62 62 101 145
GLYBURIDE 62 38 R 101 98
NITROFURANTOIN 61 60 104 273
FLUOXETINE HCL 61 36 104 72
CEFTRIAXONE 61 58 104 213
LYRICA 60 39 107 103
VERAPAMIL ER 57 53 108 89
NYSTATIN-TRIAMCINOLONE 57 51 108 280
METOCLOPRAMIDE HCL 57 51 108 121
CARISOPRODOL 55 26 R 111 123
MUPIROCIN 55 43 111 215
INSULIN SYRINGE 54 33 113 97
HYDRALAZINE HCL 52 47 114 67
ONDANSETRON HCL 52 49 114 264
OXYCODONE-ACETAMINOPHEN 51 25 S2 116 60
TRAVATAN Z 51 51 116 218
FELODIPINE ER 51 39 116 159
LEVOXYL 50 50 119 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.